Newsletter

317450 - Myungin Pharm

317450 Summary
Biopharma
Stock Price & Overview
₩44,650 +0 (+0.00%) Close · Sep 4, 2026 KST
KOSPI | ₩KRW | Close: ₩44,650  ≈ US$32  ·  Market cap ₩0.7tn (≈ $466m)
Home › 317450 › Filings

Insider / Major Shareholder Holdings Report ×3

DART
Myungin Pharm
Filed May 8, 2026 KST · Ownership · receipt 20260508000954

kstock has not written this one up. The title above is a translation of the Korean form name; the filing itself is on DART, in Korean.

Read the original on DART ↗ Korean. DART is Korea's electronic disclosure system, run by the Financial Supervisory Service — the filing equivalent of EDGAR.
Korean form name: 임원ㆍ주요주주특정증권등소유상황보고서

317450

Price
₩44,650
Change
+0.00%
Market cap
₩0.7tn
Prev. close
₩44,650
317450 SummaryCompare to Peers

More 317450 filings

Half-Year Report

08/13/26

Dividend Declared

08/06/26

Preliminary operating results (fair disclosure)

07/31/26

Dividend Declared

07/28/26

Record Date Set for a Dividend

07/28/26

Corporate governance report

06/01/26